83_FR_3170 83 FR 3155 - Submission for OMB Review; Comment Request

83 FR 3155 - Submission for OMB Review; Comment Request

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families

Federal Register Volume 83, Issue 15 (January 23, 2018)

Page Range3155-3156
FR Document2018-01140

Federal Register, Volume 83 Issue 15 (Tuesday, January 23, 2018)
[Federal Register Volume 83, Number 15 (Tuesday, January 23, 2018)]
[Notices]
[Pages 3155-3156]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-01140]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration for Children and Families


Submission for OMB Review; Comment Request

    Title: Job Search Assistance (JSA) Strategies Evaluation--
Extension.
    OMB No.: 0970-0440.
    Description: The Administration for Children and Families (ACF), is 
proposing the extension without changes to an existing data collection 
activity as part of the Job Search Assistance (JSA) Strategies 
Evaluation. The JSA evaluation will aim to determine which JSA 
strategies are most effective in moving TANF applicants and recipients 
into work and will produce impact and implementation findings. To date, 
the study has randomly assigned individuals to contrasting JSA 
approaches. The study will next compare participant employment and 
earnings to determine the relative effectiveness of these strategies. 
The project will also report on the implementation of these strategies, 
including measures of services participants receive under each 
approach, as well as provide operational lessons gathered directly from 
practitioners.
    Data collection efforts previously approved for JSA, include: Data 
collection activities to document program implementation, a staff 
survey, a baseline information form for program participants, and a 
follow-up survey for JSA participants approximately 6 months after 
program enrollment. Approval for these activities expires on February 
28, 2018.
    This Federal Register Notice provides the opportunity to comment on 
the extension of the 6-month follow-up survey to allow follow-up data 
to be collected for all study participants. Although the enrollment 
period was originally estimated to span 12 months, it took 18 months to 
complete enrollment, leaving insufficient time to complete the 6-month 
follow-up survey. A four-month extension is requested in order to allow 
individuals randomly assigned between June and August 2017 to complete 
the follow-up survey in the same timeframe as earlier enrollees. The 
purpose of the survey is to follow-up with study participants and 
document their job search assistance services and experiences including 
their receipt of job search assistance services, their knowledge and 
skills for conducting a job search, the nature of their job search 
process, including tools and services used to locate employment, and 
their search outputs and outcomes, such as the number of applications 
submitted, interviews attended, offers received and jobs obtained. In 
addition, the survey will provide an opportunity for respondents to 
provide contact data for possible longer-term follow-up. There are no 
changes to the currently approved instruments.
    Respondents: JSA study participants.
    Annual Burden Estimates: This extension is specific to the 6-month 
survey and covers the remaining 766 participants that may be completing 
the six-month follow up survey during the four-month extension period. 
All other information collection under 0970-0440 will be complete by 
the original OMB expiration date of February 28, 2018.

----------------------------------------------------------------------------------------------------------------
                                                Total/annual      Number of      Average burden
                 Instrument                      number of      responses per      hours per      Annual burden
                                                respondents       respondent        response          hours
----------------------------------------------------------------------------------------------------------------
                             Extension of Previously Approved Information Collection
----------------------------------------------------------------------------------------------------------------
6-Month Follow-Up Survey....................             766                1             .333              255
----------------------------------------------------------------------------------------------------------------

    Estimated Total Annual Burden Hours: 255.
    Additional Information: Copies of the proposed collection may be 
obtained by writing to the Administration for Children and Families, 
Office of Planning, Research and Evaluation, 330 C Street SW, 
Washington, DC 20201, Attn: OPRE Reports Clearance Officer. All 
requests should be identified by the title of the information 
collection. Email address: [email protected].
    OMB Comment: OMB is required to make a decision concerning the

[[Page 3156]]

collection of information between 30 and 60 days after publication of 
this document in the Federal Register. Therefore, a comment is best 
assured of having its full effect if OMB receives it within 30 days of 
publication. Written comments and recommendations for the proposed 
information collection should be sent directly to the following: Office 
of Management and Budget, Paperwork Reduction Project, Email: 
[email protected]. Attn: Desk Officer for the Administration 
for Children and Families.

Mary Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2018-01140 Filed 1-22-18; 8:45 am]
 BILLING CODE 4184-09-P



                                                                                   Federal Register / Vol. 83, No. 15 / Tuesday, January 23, 2018 / Notices                                                         3155

                                                3506(c)(2)(A)) requires federal agencies                          information on special topics. Form                            Data collection efforts previously
                                                to publish a 30-day notice in the                                 Number: CMS–10549 (OMB control                              approved for JSA, include: Data
                                                Federal Register concerning each                                  number 0938–1275); Frequency:                               collection activities to document
                                                proposed collection of information,                               Occasionally; Affected Public:                              program implementation, a staff survey,
                                                including each proposed extension or                              Individuals or Households; Number of                        a baseline information form for program
                                                reinstatement of an existing collection                           Respondents: 1,500; Total Annual                            participants, and a follow-up survey for
                                                of information, before submitting the                             Responses: 1,500; Total Annual Hours:                       JSA participants approximately 6
                                                collection to OMB for approval. To                                1,117. (For policy questions regarding                      months after program enrollment.
                                                comply with this requirement, CMS is                              this collection contact William Long at                     Approval for these activities expires on
                                                publishing this notice that summarizes                            410–786–7927.)                                              February 28, 2018.
                                                the following proposed collection(s) of                              Dated: January 18, 2018.                                    This Federal Register Notice provides
                                                information for public comment:                                   William N. Parham, III,                                     the opportunity to comment on the
                                                   1. Type of Information Collection
                                                                                                                  Director, Paperwork Reduction Staff, Office                 extension of the 6-month follow-up
                                                Request: Extension without change of a                            of Strategic Operations and Regulatory                      survey to allow follow-up data to be
                                                currently approved collection; Title of                           Affairs.                                                    collected for all study participants.
                                                Information Collection: Generic                                   [FR Doc. 2018–01175 Filed 1–22–18; 8:45 am]                 Although the enrollment period was
                                                Clearance for Questionnaire Testing and
                                                                                                                  BILLING CODE 4120–01–P                                      originally estimated to span 12 months,
                                                Methodological Research for the
                                                                                                                                                                              it took 18 months to complete
                                                Medicare Current Beneficiary Survey
                                                                                                                                                                              enrollment, leaving insufficient time to
                                                (MCBS); Use: The purpose of this OMB                              DEPARTMENT OF HEALTH AND                                    complete the 6-month follow-up survey.
                                                clearance package is to extend the                                HUMAN SERVICES                                              A four-month extension is requested in
                                                approval of the generic clearance to
                                                                                                                                                                              order to allow individuals randomly
                                                support an effort to evaluate the                                 Administration for Children and                             assigned between June and August 2017
                                                operations and content of the Medicare                            Families                                                    to complete the follow-up survey in the
                                                Current Beneficiary Survey (MCBS). The
                                                                                                                  Submission for OMB Review;                                  same timeframe as earlier enrollees. The
                                                MCBS is a continuous, multipurpose
                                                                                                                  Comment Request                                             purpose of the survey is to follow-up
                                                survey of a nationally representative
                                                                                                                                                                              with study participants and document
                                                sample of aged, disabled, and                                        Title: Job Search Assistance (JSA)                       their job search assistance services and
                                                institutionalized Medicare beneficiaries.                         Strategies Evaluation—Extension.                            experiences including their receipt of
                                                The MCBS, which is sponsored by the                                  OMB No.: 0970–0440.                                      job search assistance services, their
                                                Centers for Medicare & Medicaid                                      Description: The Administration for                      knowledge and skills for conducting a
                                                Services (CMS), is the only                                       Children and Families (ACF), is                             job search, the nature of their job search
                                                comprehensive source of information on                            proposing the extension without                             process, including tools and services
                                                the health status, health care use and                            changes to an existing data collection                      used to locate employment, and their
                                                expenditures, health insurance                                    activity as part of the Job Search                          search outputs and outcomes, such as
                                                coverage, and socioeconomic and                                   Assistance (JSA) Strategies Evaluation.                     the number of applications submitted,
                                                demographic characteristics of the                                The JSA evaluation will aim to                              interviews attended, offers received and
                                                entire spectrum of Medicare                                       determine which JSA strategies are most                     jobs obtained. In addition, the survey
                                                beneficiaries. The core of the MCBS is                            effective in moving TANF applicants                         will provide an opportunity for
                                                a series of interviews with a stratified                          and recipients into work and will                           respondents to provide contact data for
                                                random sample of the Medicare                                     produce impact and implementation                           possible longer-term follow-up. There
                                                population, including aged and disabled                           findings. To date, the study has                            are no changes to the currently
                                                enrollees, residing in the community or                           randomly assigned individuals to                            approved instruments.
                                                in institutions. Questions are asked                              contrasting JSA approaches. The study
                                                about enrollees’ patterns of health care                          will next compare participant                                  Respondents: JSA study participants.
                                                use, charges, insurance coverage, and                             employment and earnings to determine                           Annual Burden Estimates: This
                                                payments over time. Respondents are                               the relative effectiveness of these                         extension is specific to the 6-month
                                                asked about their sources of health care                          strategies. The project will also report                    survey and covers the remaining 766
                                                coverage and payment, their                                       on the implementation of these                              participants that may be completing the
                                                demographic characteristics, their                                strategies, including measures of                           six-month follow up survey during the
                                                health and work history, and their                                services participants receive under each                    four-month extension period. All other
                                                family living circumstances. In addition                          approach, as well as provide operational                    information collection under 0970–0440
                                                to collecting information through the                             lessons gathered directly from                              will be complete by the original OMB
                                                core questionnaire, the MCBS collects                             practitioners.                                              expiration date of February 28, 2018.

                                                                                                                                                          Total/annual       Number of           Average         Annual
                                                                                            Instrument                                                     number of       responses per       burden hours   burden hours
                                                                                                                                                          respondents        respondent        per response

                                                                                                            Extension of Previously Approved Information Collection

                                                6-Month Follow-Up Survey ..............................................................................         766               1                .333           255
sradovich on DSK3GMQ082PROD with NOTICES




                                                  Estimated Total Annual Burden                                   Children and Families, Office of                            title of the information collection. Email
                                                Hours: 255.                                                       Planning, Research and Evaluation, 330                      address: OPREinfocollection@
                                                  Additional Information: Copies of the                           C Street SW, Washington, DC 20201,                          acf.hhs.gov.
                                                proposed collection may be obtained by                            Attn: OPRE Reports Clearance Officer.                          OMB Comment: OMB is required to
                                                writing to the Administration for                                 All requests should be identified by the                    make a decision concerning the


                                           VerDate Sep<11>2014      17:59 Jan 22, 2018      Jkt 244001     PO 00000     Frm 00046      Fmt 4703     Sfmt 4703   E:\FR\FM\23JAN1.SGM   23JAN1


                                                3156                          Federal Register / Vol. 83, No. 15 / Tuesday, January 23, 2018 / Notices

                                                collection of information between 30                    docket number is FDA–2018–N–0045.                      identified, as confidential, if submitted
                                                and 60 days after publication of this                   The docket will close on March 23,                     as detailed in ‘‘Instructions.’’
                                                document in the Federal Register.                       2018. Submit either electronic or                         Instructions: All submissions received
                                                Therefore, a comment is best assured of                 written comments on this public                        must include Docket No. FDA–2018–N–
                                                having its full effect if OMB receives it               meeting by that date. Please note that                 0045 for ‘‘Pediatric Advisory Committee
                                                within 30 days of publication. Written                  late, untimely comments will not be                    and the Endocrinologic and Metabolic
                                                comments and recommendations for the                    considered. The https://                               Drugs Advisory Committee; Notice of
                                                proposed information collection should                  www.regulations.gov electronic filing                  Meeting; Establishment of a Public
                                                be sent directly to the following: Office               system will accept comments until                      Docket; Request for Comments.’’
                                                of Management and Budget, Paperwork                     midnight Eastern Time at the end of                    Received comments, those filed in a
                                                Reduction Project, Email: OIRA_                         March 23, 2018. Comments received by                   timely manner (see ADDRESSES), will be
                                                SUBMISSION@OMB.EOP.GOV. Attn:                           mail/hand delivery/courier (for written/               placed in the docket and, except for
                                                Desk Officer for the Administration for                 paper submissions) will be considered                  those submitted as ‘‘Confidential
                                                Children and Families.                                  timely if they are postmarked or the                   Submissions,’’ publicly viewable at
                                                                                                        delivery service acceptance receipt is on              https://www.regulations.gov or at the
                                                Mary Jones,
                                                                                                        or before that date.                                   Dockets Management Staff between 9
                                                ACF/OPRE Certifying Officer.                               Comments received on or before                      a.m. and 4 p.m., Monday through
                                                [FR Doc. 2018–01140 Filed 1–22–18; 8:45 am]             March 8, 2018, will be provided to the                 Friday.
                                                BILLING CODE 4184–09–P                                  committee. Comments received after                        • Confidential Submissions—To
                                                                                                        that date will be taken into                           submit a comment with confidential
                                                                                                        consideration by FDA.                                  information that you do not wish to be
                                                DEPARTMENT OF HEALTH AND                                   You may submit comments as                          made publicly available, submit your
                                                HUMAN SERVICES                                          follows:                                               comments only as a written/paper
                                                Food and Drug Administration                            Electronic Submissions                                 submission. You should submit two
                                                                                                                                                               copies total. One copy will include the
                                                [Docket No. FDA–2018–N–0045]                              Submit electronic comments in the                    information you claim to be confidential
                                                                                                        following way:                                         with a heading or cover note that states
                                                Pediatric Advisory Committee and the                      • Federal eRulemaking Portal:                        ‘‘THIS DOCUMENT CONTAINS
                                                Endocrinologic and Metabolic Drugs                      https://www.regulations.gov. Follow the                CONFIDENTIAL INFORMATION.’’ FDA
                                                Advisory Committee; Notice of                           instructions for submitting comments.                  will review this copy, including the
                                                Meeting; Establishment of a Public                      Comments submitted electronically,                     claimed confidential information, in its
                                                Docket; Request for Comments                            including attachments, to https://                     consideration of comments. The second
                                                                                                        www.regulations.gov will be posted to                  copy, which will have the claimed
                                                AGENCY:    Food and Drug Administration,
                                                                                                        the docket unchanged. Because your                     confidential information redacted/
                                                HHS.
                                                                                                        comment will be made public, you are                   blacked out, will be available for public
                                                ACTION: Notice; establishment of a                      solely responsible for ensuring that your
                                                public docket; request for comments.                                                                           viewing and posted on https://
                                                                                                        comment does not include any                           www.regulations.gov. Submit both
                                                SUMMARY:   The Food and Drug                            confidential information that you or a                 copies to the Dockets Management Staff.
                                                Administration (FDA) announces a                        third party may not wish to be posted,                 If you do not wish your name and
                                                forthcoming public advisory committee                   such as medical information, your or                   contact information be made publicly
                                                meeting of the Pediatric Advisory                       anyone else’s Social Security number, or               available, you can provide this
                                                Committee (PAC) and the                                 confidential business information, such                information on the cover sheet and not
                                                Endocrinologic and Metabolic Drugs                      as a manufacturing process. Please note                in the body of your comments and you
                                                Advisory Committee (EMDAC). At least                    that if you include your name, contact                 must identify the information as
                                                one portion of the meeting will be                      information, or other information that                 ‘‘confidential.’’ Any information marked
                                                closed to the public. The general                       identifies you in the body of your                     as ‘‘confidential’’ will not be disclosed
                                                function of the committees is to provide                comments, that information will be                     except in accordance with 21 CFR 10.20
                                                advice and recommendations to FDA on                    posted on https://www.regulations.gov.                 and other applicable disclosure law. For
                                                regulatory issues. FDA is establishing a                  • If you want to submit a comment
                                                                                                                                                               more information about FDA’s posting
                                                docket for public comments on this                      with confidential information that you
                                                                                                                                                               of comments to public dockets, see 80
                                                document.                                               do not wish to be made available to the
                                                                                                                                                               FR 56469, September 18, 2015, or access
                                                                                                        public, submit the comment as a
                                                DATES: The meeting will be held on                                                                             the information at: https://www.gpo.gov/
                                                                                                        written/paper submission and in the
                                                March 22, 2018, from 8:30 a.m. to 5:30                                                                         fdsys/pkg/FR-2015-09-18/pdf/2015-
                                                                                                        manner detailed (see ‘‘Written/Paper
                                                p.m.                                                                                                           23389.pdf.
                                                                                                        Submissions’’ and ‘‘Instructions’’).
                                                ADDRESSES: FDA White Oak Campus,                                                                                  Docket: For access to the docket to
                                                10903 New Hampshire Ave., Building                      Written/Paper Submissions                              read background documents or the
                                                31 Conference Center, the Great Room                      Submit written/paper submissions as                  electronic and written/paper comments
                                                (Rm. 1503), Silver Spring, MD 20993–                    follows:                                               received, go to https://
                                                0002. Answers to commonly asked                           • Mail/Hand delivery/Courier (for                    www.regulations.gov and insert the
                                                questions including information                         written/paper submissions): Dockets                    docket number, found in brackets in the
                                                                                                                                                               heading of this document, into the
sradovich on DSK3GMQ082PROD with NOTICES




                                                regarding special accommodations due                    Management Staff (HFA–305), Food and
                                                to a disability, visitor parking, and                   Drug Administration, 5630 Fishers                      ‘‘Search’’ box and follow the prompts
                                                transportation may be accessed at:                      Lane, Rm. 1061, Rockville, MD 20852.                   and/or go to the Dockets Management
                                                https://www.fda.gov/Advisory                              • For written/paper comments                         Staff, 5630 Fishers Lane, Rm. 1061,
                                                Committees/AboutAdvisoryCommittees/                     submitted to the Dockets Management                    Rockville, MD 20852.
                                                ucm408555.htm.                                          Staff, FDA will post your comment, as                  FOR FURTHER INFORMATION CONTACT:
                                                   FDA is establishing a docket for                     well as any attachments, except for                    Marieann Brill, Office of the
                                                public comment on this meeting. The                     information submitted, marked and                      Commissioner, Food and Drug


                                           VerDate Sep<11>2014   17:59 Jan 22, 2018   Jkt 244001   PO 00000   Frm 00047   Fmt 4703   Sfmt 4703   E:\FR\FM\23JAN1.SGM   23JAN1



Document Created: 2018-01-23 01:09:06
Document Modified: 2018-01-23 01:09:06
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
FR Citation83 FR 3155 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR